Veteran investment professional focused on growth equity and operational value creation across technology and healthcare, with experience sourcing deals, leading follow-on rounds and partnering with founders to scale revenue and margins. Debbie Fox combines operating leadership and investor diligence, with a background in corporate strategy, portfolio operations and fund-level governance.
Veteran investment professional focused on growth equity and operational value creation across technology and healthcare, with experience sourcing deals, leading follow-on rounds and partnering with founders to scale revenue and margins. Debbie Fox combines operating leadership and investor diligence, with a background in corporate strategy, portfolio operations and fund-level governance.
Focuses on growth equity investments in technology and healthcare, prioritizing scalable business models where operational improvements can unlock margin expansion and revenue acceleration. Emphasizes founder alignment, disciplined follow-on capital allocation, and rigorous diligence that blends corporate-strategy thinking with hands-on portfolio operations. Seeks companies with clear go-to-market leverage, durable unit economics, and pathways to market leadership where active governance and KPI-driven operational interventions drive value. Time horizon is growth-stage multi-year scaling rather than short-term exits; risk management centers on staging capital, milestone-based value creation plans, and close operator-investor collaboration.
Focuses on growth equity investments in technology and healthcare, prioritizing scalable business models where operational improvements can unlock margin expansion and revenue acceleration. Emphasizes founder alignment, disciplined follow-on capital allocation, and rigorous diligence that blends corporate-strategy thinking with hands-on portfolio operations. Seeks companies with clear go-to-market leverage, durable unit economics, and pathways to market leadership where active governance and KPI-driven operational interventions drive value. Time horizon is growth-stage multi-year scaling rather than short-term exits; risk management centers on staging capital, milestone-based value creation plans, and close operator-investor collaboration.
| Trades 957 | Longs Won 629/957 65% | Profit Factor 6.43 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $427,719.4 |
| Average Win $132,928.34 | Best Trade (Oct 16) $6.09M | Sharpe Ratio -10.46 |
| Average Loss -$39,658.57 | Worst Trade (Oct 15) -$982,986.35 | Z-Score 4.55 (100%) |
| Commissions $0 | Avg. Trade Length 11m 2w 2d | Expectancy $73,776.3 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 8,000 | 7,200 | 6,400 | 5,600 | 4,800 | 4,000 | 3,200 | 2,400 | 1,600 | 800 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 64,214 | $16.08M | $22.17M | - | $6.09M | 37.89% | +0.968% |
ABBNY ABB Ltd. Sponsored ADR | 2,300 | $249,717 | $212,980 | - | -$36,737 | -14.71% | -0.086% |
ABBV AbbVie Inc. | 5,258 | $1.05M | $1.5M | - | $447,709.81 | 42.45% | +0.826% |
ABT Abbott Laboratories | 18,978 | $2.17M | $1.99M | - | -$180,431.94 | -8.3% | +0.382% |
ACN Accenture plc Class A | 11,706 | $3.2M | $2.66M | - | -$540,203.97 | -16.88% | +1.045% |
ADBE Adobe Inc. | 1,186 | $499,771.27 | $292,609.92 | - | -$207,161.35 | -41.45% | -1.967% |
ADI Analog Devices, Inc. | 10,398 | $2.26M | $4.24M | - | $1.98M | 87.42% | +0.916% |
ADP Automatic Data Processing Inc. | 1,314 | $372,497.08 | $376,920.9 | - | $4,423.82 | 1.19% | +0.42% |
ADSK Autodesk, Inc. | 4,129 | $885,073.48 | $1M | - | $116,580.63 | 13.17% | -1.048% |
AEP American Electric Power Company, Inc. | 1,500 | $205,215 | $189,405 | - | -$15,810 | -7.7% | +1.593% |
AFL Aflac Inc. | 6,531 | $675,566.8 | $777,058.38 | - | $101,491.58 | 15.02% | +0.788% |
AJG Arthur J. Gallagher & Co. | 1,050 | $291,316 | $265,702.5 | - | -$25,613.5 | -8.79% | +1.18% |
ALC Alcon Inc. | 4,874 | $412,609.51 | $324,657.14 | - | -$87,952.37 | -21.32% | +0.045% |
ALL Allstate Corporation | 3,270 | $630,423.44 | $797,258.7 | - | $166,835.26 | 26.46% | +1.757% |
AMAT Applied Materials, Inc. | 12,036 | $2.28M | $5.07M | - | $2.79M | 122.42% | -2.079% |
AMD Advanced Micro Devices, Inc. | 9,023 | $1.82M | $4.91M | - | $3.08M | 169.25% | -3.301% |
AMGN Amgen Inc. | 1,979 | $592,246.25 | $866,109.35 | - | $273,863.1 | 46.24% | +0.834% |
AMLP Alerian MLP ETF | 12,064 | $631,217.34 | $631,248.8 | - | $31.46 | - | +0.799% |
AMT American Tower Corporation | 1,314 | $272,313.64 | $241,427.79 | - | -$30,885.85 | -11.34% | +1.31% |
AMZN Amazon.com Inc | 21,157 | $4.64M | $5.39M | - | $751,527.16 | 16.21% | -0.047% |